Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Fatigue 1

Interventions

Rituximab 1402Cyclophosphamide 1308Vincristine 670Doxorubicin 589Etoposide 527Prednisone 512Cytarabine 487fludarabine 470Methotrexate 446Dexamethasone 414fludarabine phosphate 400Lenalidomide 356Filgrastim 343Bendamustine Hydrochloride 283Radiotherapy 267venetoclax 261ibrutinib 258obinutuzumab 236Peripheral Blood Stem Cell Transplantation 234Melphalan 230Granulocyte Colony-Stimulating Factor 215Bortezomib 204Gemcitabine 202Busulfan 188Whole-Body Irradiation 187Mycophenolic Acid 175Tacrolimus 165Specimen Handling 164Magnetic Resonance Spectroscopy 157Calcium Dobesilate 151

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
AIEOP acute lymphoblastic leukemia protocol × Lymphoid × Clear all
NCT06184009 2025-06-08

HR ALL

Seoul St. Mary's Hospital

Phase 2 Recruiting
370 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04406285 2020-05-28

Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent.

Federal University of Health Science of Porto Alegre

Phase NA Unknown
66 enrolled
LymphoidOther hematologic neoplasm

Fatigue, Leukemia, Lymphoma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡